Ackman's Pershing Square ends 2015 with 20.5 pct drop

Go back to Ackman's Pershing Square ends 2015 with 20.5 pct drop

Valeant Pharma (VRX) Sees Sharp Upside

January 5, 2016 10:53 AM EST

Valeant Pharma (NYSE: VRX) is seeing upside today. Chatter is that either Bill Ackman is buying back the stock that he recently sold for tax purposes and/or CEO Mike Pearson's condition is improving. Shares are up 4.8%.

... More